Suppr超能文献

硬膜外麻醉复合全身麻醉与单纯全身麻醉的长期生存比较:一项随机试验的随访。

Long-term Survival after Combined Epidural-General Anesthesia or General Anesthesia Alone: Follow-up of a Randomized Trial.

出版信息

Anesthesiology. 2021 Aug 1;135(2):233-245. doi: 10.1097/ALN.0000000000003835.

Abstract

BACKGROUND

Experimental and observational research suggests that combined epidural-general anesthesia may improve long-term survival after cancer surgery by reducing anesthetic and opioid consumption and by blunting surgery-related inflammation. This study therefore tested the primary hypothesis that combined epidural-general anesthesia improves long-term survival in elderly patients.

METHODS

This article presents a long-term follow-up of patients enrolled in a previous trial conducted at five hospitals. Patients aged 60 to 90 yr and scheduled for major noncardiac thoracic and abdominal surgeries were randomly assigned to either combined epidural-general anesthesia with postoperative epidural analgesia or general anesthesia alone with postoperative intravenous analgesia. The primary outcome was overall postoperative survival. Secondary outcomes included cancer-specific, recurrence-free, and event-free survival.

RESULTS

Among 1,802 patients who were enrolled and randomized in the underlying trial, 1,712 were included in the long-term analysis; 92% had surgery for cancer. The median follow-up duration was 66 months (interquartile range, 61 to 80). Among patients assigned to combined epidural-general anesthesia, 355 of 853 (42%) died compared with 326 of 859 (38%) deaths in patients assigned to general anesthesia alone: adjusted hazard ratio, 1.07; 95% CI, 0.92 to 1.24; P = 0.408. Cancer-specific survival was similar with combined epidural-general anesthesia (327 of 853 [38%]) and general anesthesia alone (292 of 859 [34%]): adjusted hazard ratio, 1.09; 95% CI, 0.93 to 1.28; P = 0.290. Recurrence-free survival was 401 of 853 [47%] for patients who had combined epidural-general anesthesia versus 389 of 859 [45%] with general anesthesia alone: adjusted hazard ratio, 0.97; 95% CI, 0.84 to 1.12; P = 0.692. Event-free survival was 466 of 853 [55%] in patients who had combined epidural-general anesthesia versus 450 of 859 [52%] for general anesthesia alone: adjusted hazard ratio, 0.99; 95% CI, 0.86 to 1.12; P = 0.815.

CONCLUSIONS

In elderly patients having major thoracic and abdominal surgery, combined epidural-general anesthesia with epidural analgesia did not improve overall or cancer-specific long-term mortality. Nor did epidural analgesia improve recurrence-free survival. Either approach can therefore reasonably be selected based on patient and clinician preference.

摘要

背景

实验和观察性研究表明,硬膜外-全身麻醉联合应用可能通过减少麻醉和阿片类药物的消耗以及减轻手术相关炎症来改善癌症手术后的长期生存率。因此,本研究检验了主要假设,即硬膜外-全身麻醉联合应用可改善老年患者的长期生存率。

方法

本文介绍了先前在五家医院进行的一项试验的长期随访结果。年龄在 60 至 90 岁之间、计划接受非心脏大胸和腹部手术的患者被随机分配至接受硬膜外-全身麻醉联合术后硬膜外镇痛或全身麻醉联合术后静脉内镇痛。主要结局是术后总体生存情况。次要结局包括癌症特异性、无复发和无事件生存情况。

结果

在基础试验中纳入并随机分组的 1802 例患者中,有 1712 例患者纳入长期分析;92%的患者因癌症接受手术。中位随访时间为 66 个月(四分位间距,61 至 80)。在接受硬膜外-全身麻醉联合应用的患者中,853 例中有 355 例(42%)死亡,而在接受单纯全身麻醉的 859 例患者中有 326 例(38%)死亡:调整后的危险比为 1.07;95%CI,0.92 至 1.24;P=0.408。接受硬膜外-全身麻醉联合应用的患者的癌症特异性生存率与单纯全身麻醉相似(853 例中有 327 例[38%]):调整后的危险比为 1.09;95%CI,0.93 至 1.28;P=0.290。接受硬膜外-全身麻醉联合应用的患者的无复发生存率为 853 例中的 401 例(47%),而接受单纯全身麻醉的患者为 859 例中的 389 例(45%):调整后的危险比为 0.97;95%CI,0.84 至 1.12;P=0.692。接受硬膜外-全身麻醉联合应用的患者的无事件生存率为 853 例中的 466 例(55%),而接受单纯全身麻醉的患者为 859 例中的 450 例(52%):调整后的危险比为 0.99;95%CI,0.86 至 1.12;P=0.815。

结论

在接受大胸和腹部手术的老年患者中,硬膜外-全身麻醉联合应用加硬膜外镇痛并未改善总体或癌症特异性的长期死亡率。硬膜外镇痛也未改善无复发生存率。因此,这两种方法都可以根据患者和临床医生的偏好进行合理选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验